linker-mm1 study: linvoseltamab (regn5458) in patients with rr multiple myeloma | asco 2023
Published 1 year ago • 564 plays • Length 10:57Download video MP4
Download video MP3
Similar videos
-
8:13
linker-mm1 study: linvoseltamab (regn5458) in relapsed/refractory myeloma | hans lee, md | asco 2023
-
5:15
linker-mm1: linvoseltamab in patients with r/r multiple myeloma
-
4:00
updates from linker-mm1: safety and efficacy of linvoseltamab in patients with r/r multiple myeloma
-
5:51
hans lee, md, on the linker-mm1 study of linvoseltamab in multiple myeloma
-
9:22
ash23: response to linvoseltamab in relapsed myeloma patients – linker-mm1 study | hans lee, md
-
3:35
linvoseltamab efficacy in high-risk rrmm: linker-mm1 study | attaya suvannasankha, md | ims 2024
-
2:59
the efficacy of linvoseltamab in prespecified high-risk subgroups in the linker-mm1 study
-
3:12
updated results of the linker-mm1 trial: linvoseltamab in r/r multiple myeloma
-
1:23
dr lentzsch on results for linvoseltamab in heavily pretreated r/r myeloma
-
2:57
linker-mm1: promising safety and efficacy of linvoseltamab in r/r multiple myeloma
-
4:45
a first-in-human trial of linvoseltamab (regn5458) in r/r myeloma: updated phase i data
-
7:40
results of bispecific antibody combination in advanced myeloma | yael cohen, md | asco 2023
-
9:56
ide-cel vs standard regimens for high-risk multiple myeloma: karmma-3 analysis | asco 2023
-
10:16
top multiple myeloma abstracts presented at asco and eha 2022
-
6:54
elranatamab: extended follow-up & biweekly admin for rrmm | magnetismm-3 study | asco 2023
-
2:28
the encouraging results of the linker-mm1 trial: safety and efficacy of linvoseltamab in r/r myeloma
-
1:05:39
imwg conference series: asco & eha 2023
-
7:36
top multiple myeloma research presented at asco and eha 2023